Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Open or close the search fields display
18 Studies found for: ALEMTUZUMAB AND Lymphocytic AND residual disease

Terms and Synonyms Searched:

Terms Search Results* Entire Database**
Synonyms
ALEMTUZUMAB 18 studies 389 studies
campath 9 studies 254 studies
MabCampath 6 studies 31 studies
anti-CD52 monoclonal antibody 1 studies 19 studies
Lemtrada 1 studies 30 studies
MoAb CD52 1 studies 9 studies
Monoclonal Antibody CD52 1 studies 9 studies
Anti-CD52 Antibody -- 6 studies
LDP-03 -- 3 studies
Lymphocytic 18 studies 2,277 studies
residual disease 18 studies 1,806 studies
Residual Tumor -- 398 studies
disease 18 studies 284,801 studies
Disorders 18 studies 102,501 studies
condition 2 studies 41,378 studies
residual 18 studies 8,118 studies
aftereffects -- 67 studies
late effects -- 267 studies
sequelae -- 981 studies

   
-- No studies found
* Number of studies in the search results containing the term or synonym
** Number of studies in the entire database containing the term or synonym